Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ARTEMIS MEDICARE SERVICES 2021-22 Annual Report Analysis
Sat, 25 Jun

ARTEMIS MEDICARE SERVICES has announced its results for the year ended March 2022. Let us have a look at the detailed performance review of the company during FY21-22.

ARTEMIS MEDICARE SERVICES Income Statement Analysis

  • Operating income during the year rose 35.8% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 75.5% YoY during the fiscal. Operating profit margins witnessed a fall and down at 12.2% in FY22 as against 9.4% in FY21.
  • Depreciation charges increased by 3.2% and finance costs decreased by 7.4% YoY, respectively.
  • Other income grew by 10.2% YoY.
  • Net profit for the year grew by 409.8% YoY.
  • Net profit margins during the year grew from 1.5% in FY21 to 5.7% in FY22.

ARTEMIS MEDICARE SERVICES Income Statement 2021-22

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Net Sales Rs m 4,084 5,548 35.8%
Other income Rs m 35 39 10.2%
Total Revenues Rs m 4,119 5,587 35.6%
Gross profit Rs m 384 675 75.5%
Depreciation Rs m 215 222 3.2%
Interest Rs m 129 120 -7.4%
Profit before tax Rs m 75 372 393.8%
Tax Rs m 14 58 322.1%
Profit after tax Rs m 62 314 409.8%
Gross profit margin % 9.4 12.2
Effective tax rate % 18.2 15.6
Net profit margin % 1.5 5.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF

ARTEMIS MEDICARE SERVICES Balance Sheet Analysis

  • The company's current liabilities during FY22 stood at Rs 1 billion as compared to Rs 1 billion in FY21, thereby witnessing an increase of 16.6%.
  • Long-term debt stood at Rs 2 billion as compared to Rs 1 billion during FY21, a growth of 49.7%.
  • Current assets rose 16% and stood at Rs 1 billion, while fixed assets rose 20% and stood at Rs 6 billion in FY22.
  • Overall, the total assets and liabilities for FY22 stood at Rs 7 billion as against Rs 6 billion during FY21, thereby witnessing a growth of 19%.

ARTEMIS MEDICARE SERVICES Balance Sheet as on March 2022

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Networth Rs m 3,202 3,517 9.8
 
Current Liabilities Rs m 1,185 1,382 16.6
Long-term Debt Rs m 1,077 1,613 49.7
Total Liabilities Rs m 6,086 7,265 19.4
 
Current assets Rs m 1,095 1,270 16.1
Fixed Assets Rs m 4,992 5,994 20.1
Total Assets Rs m 6,086 7,265 19.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



ARTEMIS MEDICARE SERVICES Cash Flow Statement Analysis

  • ARTEMIS MEDICARE SERVICES's cash flow from operating activities (CFO) during FY22 stood at Rs 596 million, an improvement of 118.6% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY22 stood at Rs -1 billion, an improvement of 186.5% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY22 stood at Rs 442 million, an improvement of 149% on a YoY basis.
  • Overall, net cash flows for the company during FY22 stood at Rs -35 million from the Rs 76 million net cash flows seen during FY21.

ARTEMIS MEDICARE SERVICES Cash Flow Statement 2021-22

Particulars No. of months 12 12 % Change
Year Ending Mar-21 Mar-22
Cash Flow from Operating Activities Rs m 273 596 118.6%
Cash Flow from Investing Activities Rs m -374 -1,072 -
Cash Flow from Financing Activities Rs m 177 442 149.4%
Net Cash Flow Rs m 76 -35 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for ARTEMIS MEDICARE SERVICES

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 2.4, an decline from the EPS of Rs 4.7 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 40.2, stands at 17.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 1.5 times, while the price to sales ratio stands at 1.0 times.
  • The company's price to cash flow (P/CF) ratio stood at 55.1 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Sales per share (Unadj.) Rs 308.5 41.9
TTM Earnings per share Rs 4.7 2.4
Diluted earnings per share Rs 0.5 2.4
Price to Cash Flow x 106.6 55.1
TTM P/E ratio x 478.5 17.0
Price / Book Value ratio x 0.8 8.4
Market Cap Rs m 2,580 29,553
Dividends per share (Unadj.) Rs 0.0 0.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for ARTEMIS MEDICARE SERVICES

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 0.9x during FY22, from 0.9x during FY21. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 4.1x during FY22, from 1.6x during FY21. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 8.9% during FY22, from 1.9% during FY22. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 9.6% during FY22, from 4.8% during FY21. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 6.0% during FY22, from 3.1% during FY21. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Current ratio x 0.9 0.9
Debtors’ Days Days 489 483
Interest coverage x 1.6 4.1
Debt to equity ratio x 0.3 0.5
Return on assets % 3.1 6.0
Return on equity % 1.9 8.9
Return on capital employed % 4.8 9.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how ARTEMIS MEDICARE SERVICES has performed over the last 5 years, please visit here.

ARTEMIS MEDICARE SERVICES Share Price Performance

Over the last one year, ARTEMIS MEDICARE SERVICES share price has moved down from Rs 301.9 to Rs 40.2, registering a loss of Rs 261.8 or around 86.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,666.4 (up 0.6%). Over the last one year it has moved down from 25,099.5 to 21,666.4, a loss of 3,433 points (down 13.7%).

Overall, the S&P BSE SENSEX is up 0.8% over the year.

(To know more, check out historical annual results for ARTEMIS MEDICARE SERVICES and quarterly results for ARTEMIS MEDICARE SERVICES)

Annual Report FAQs

What is the current share price of ARTEMIS MEDICARE SERVICES?

ARTEMIS MEDICARE SERVICES currently trades at Rs 177.5 per share. You can check out the latest share price performance of ARTEMIS MEDICARE SERVICES here...

What was the revenue of ARTEMIS MEDICARE SERVICES in FY22? How does it compare to earlier years?

The revenues of ARTEMIS MEDICARE SERVICES stood at Rs 5,587 m in FY22, which was up 35.6% compared to Rs 4,119 m reported in FY21.

ARTEMIS MEDICARE SERVICES' revenue has grown from Rs 5,067 m in FY18 to Rs 5,587 m in FY22.

Over the past 5 years, the revenue of ARTEMIS MEDICARE SERVICES has grown at a CAGR of 2.5%.

What was the net profit of ARTEMIS MEDICARE SERVICES in FY22? How does it compare to earlier years?

The net profit of ARTEMIS MEDICARE SERVICES stood at Rs 314 m in FY22, which was up 409.8% compared to Rs 62 m reported in FY21.

This compares to a net profit of Rs 195 m in FY20 and a net profit of Rs 204 m in FY19.

Over the past 5 years, ARTEMIS MEDICARE SERVICES net profit has grown at a CAGR of 4.1%.

What does the cash flow statement of ARTEMIS MEDICARE SERVICES reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of ARTEMIS MEDICARE SERVICES reveals:

  • Cash flow from operations increased in FY22 and stood at Rs 596 m as compared to Rs 273 m in FY21.
  • Cash flow from investments decreased in FY22 and stood at Rs -1,072 m as compared to Rs -374 m in FY21.
  • Cash flow from financial activity increased in FY22 and stood at Rs 442 m as compared to Rs 177 m in FY21.

Here's the cash flow statement of ARTEMIS MEDICARE SERVICES for the past 5 years.

(Rs m)FY18FY19FY20FY21FY22
From Operations719404561273596
From Investments-666-496-263-374-1,072
From Financial Activity-97144-274177442
Net Cashflow-43532476-35

What does the Key Ratio analysis of ARTEMIS MEDICARE SERVICES reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of ARTEMIS MEDICARE SERVICES reveals:

  • Operating profit margins witnessed a fall and down at 12.2% in FY22 as against 9.4% in FY21.
  • Net profit margins grew from 1.5% in FY21 to 5.7% in FY22.
  • Debt to Equity ratio for FY22 stood at 0.5 as compared to 0.3 in FY21.

Here's the ratio/financial analysis of ARTEMIS MEDICARE SERVICES for the past 5 years.

 FY18FY19FY20FY21FY22
Operating Profit Margin (%)11.811.710.99.412.2
Net Profit Margin (%)5.33.73.41.55.7
Debt to Equity Ratio (x)0.20.20.20.30.5

Read: Latest Annual Report Analysis of ARTEMIS MEDICARE SERVICES

Equitymaster requests your view! Post a comment on "ARTEMIS MEDICARE SERVICES 2021-22 Annual Report Analysis". Click here!